Google has started integrating its experimental medical AI, AMIE, into telehealth platforms for real-time clinical video consultations. The move puts the system, which stands for Articulated Medical Intelligence Explorer, directly in front of physicians and patients during live visits.
What AMIE does in a live visit
AMIE is designed to assist doctors during video consultations, not replace them. The AI listens to the conversation, processes clinical information, and can offer suggestions that might improve diagnostic accuracy and efficiency. It works under physician supervision, meaning the doctor stays in control of decisions.
The integration into telehealth is a practical step. Instead of being a research tool locked in a lab, AMIE now operates in a real clinical setting. That's a significant shift from earlier stages, where the system was tested on simulated conversations.
Why supervision matters
Google is positioning AMIE as a support tool. The company says the AI could help doctors catch details they might miss, especially during long or complex consultations. But the emphasis on physician supervision is deliberate. The system isn't making independent judgments; it's offering input that a human clinician can accept, reject, or modify.
That distinction matters for regulatory and trust reasons. Telehealth has grown quickly, and adding AI to the mix raises questions about liability and patient safety. By keeping a doctor in the loop, Google is trying to address those concerns before they become problems.
What's still unknown
Google hasn't said which telehealth providers are using AMIE or when it might become widely available. The company also hasn't released data on how much AMIE improves diagnostic accuracy in real-world use. The claims about efficiency and accuracy are based on internal testing, not independent studies.
There's also the question of how AMIE handles sensitive patient data. Video consultations involve protected health information, and any AI processing that data needs to comply with privacy regulations. Google hasn't detailed those safeguards yet.
The next step is likely a broader rollout, but that depends on how the initial integration performs. Doctors who use AMIE will have to report on their experience, and Google will need to show that the system adds value without adding risk. Until then, AMIE remains a promising experiment with a live audience.
